135 results
8-K
EX-2.1
HGENQ
Humanigen, Inc
8 Jan 24
Entry into a Material Definitive Agreement
5:02pm
that are majority funded by its partners; a leading network of centers, The Mayo Clinics, is currently progressing with an investigator-initiated trial … benefit plans or arrangements.
(mmmmm) “Subsidiary” means, with respect to any Person, any corporation of which a majority of the total voting power
8-K
HGENQ
Humanigen, Inc
24 Jul 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:25pm
of a majority of independent directors; and Nasdaq Rule 5605(c)(2), which requires a Nasdaq-listed company to have an audit committee of the board of directors
8-K
EX-99.1
oxbxdkogrccc7ut f9u
14 Nov 22
Humanigen Reports Third Quarter 2022 Financial Results
4:16pm
8-K
EX-99.1
n1m j9akizv7w
12 Aug 22
Humanigen Reports Second Quarter 2022 Financial Results
4:07pm
8-K
EX-99.1
bittv8h9mhms
26 Jul 22
Humanigen Implements Strategic Realignment of Pipeline and Resources to Achieve Key Clinical Milestones
4:05pm
424B5
rvg9ac0c wo9c54oip2
14 Apr 22
Prospectus supplement for primary offering
5:27pm
8-K
EX-10.1
yar6ufd4r3ri 3t
12 Apr 22
Other Events
4:07pm
8-K
98ul682bcelodo6e8175
5 Jan 22
Other Events
6:04am
8-K
EX-99.1
idn5l8
14 Sep 21
Regulation FD Disclosure
5:00pm
424B5
vfp98
13 Aug 21
Prospectus supplement for primary offering
5:08pm